Johnson & Johnson (NYSE:JNJ) last traded at $168.74. The stock is up over 3% over the course of the year.
Johnson & Johnson is set to report earnings before the bell and hold a conference call at 8:30 a.m. ET. Analysts expect single-digit earnings growth for the company. The company’s strong sales from its pharmaceutical division helped beat expectations last quarter, but this quarter may be impacted by Covid-related headwinds and other macroeconomic factors.
One potential wild card could be the company’s full-year guidance. Historically, Johnson & Johnson has beaten earnings expectations 95% of the time and the stock averages a gain of 0.27% on earnings days, although it fell after the last two reports were released.
